Improving the treatment of neuropsychiatric symptoms in nursing home residents suffering from dementia
| ISRCTN | ISRCTN43578978 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN43578978 |
| Protocol serial number | LT 44-076 |
| Sponsor | Federal Office of Administration (Bundesverwaltungsamt [BVA]) (Germany) |
| Funder | German Federal Ministry of Health (Bundesministerium für Gesundheit [BMG]) (ref: LT 44-076) |
- Submission date
- 30/01/2010
- Registration date
- 10/06/2010
- Last edited
- 25/04/2014
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Mental and Behavioural Disorders
Plain English summary of protocol
Not provided at time of registration
Contact information
Scientific
Psychiatric University Hospital St. Hedwig
Grosse Hamburger Str. 5-11
Berlin
10115
Germany
| Phone | +49 2311 2057 |
|---|---|
| michael.rapp@charite.de |
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Cluster randomised controlled trial |
| Secondary study design | Randomised controlled trial |
| Study type | Participant information sheet |
| Scientific title | Evaluation of a combined guideline implementation protocol for neuropsychiatric symptoms in nursing home residents suffering from dementia |
| Study acronym | VIDEANT |
| Study objectives | The implementation of guideline-driven training and occupational therapy interventions will reduce neuropsychiatric symptoms, specifically, agitation, depression, and apathy, in nursing home residents suffering from dementia |
| Ethics approval(s) | Ethics Committee of Charite - University Medicine Berlin approved on the 17th of July 2008 (ref: EA1/065/08) |
| Health condition(s) or problem(s) studied | Neuropsychiatric symptoms in dementia |
| Intervention | 18 care centres in Berlin will be randomised to the intervention or control conditions: 1. Intervention centres: 1.1. 20 hours of training for nursing staff on causes, symptomatology and treatment of neuropsychiatric symptoms in dementia 1.2. 4 hours of training for primary care psychiatrists on causes and medical treatment of neuropsychiatric symptoms in dementia 1.3. 15 minute individual occupational therapy sessions twice a week 1.4. Provision of and training in standardized assessments of neuropsychiatric symptoms in dementia (nursing staff) 2. Control centres: treatment as usual The total duration of the intervention and follow up will be 9 months |
| Intervention type | Other |
| Primary outcome measure(s) |
1. Agitation as measured with the Cohen-Mansfield Agitation inventory (CMAI) |
| Key secondary outcome measure(s) |
1. Psychotropic medication in defined daily dosages |
| Completion date | 01/05/2010 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Senior |
| Sex | All |
| Target sample size at registration | 400 |
| Key inclusion criteria | Both male and female dementia patients aged 60 or older who live in a nursing home |
| Key exclusion criteria | 1. Inability to give informed consent and absence of a caregiver holding power of attorney 2. Any of the following conditions as defined by ICD-10 criteria 2.1. Presence of substance abuse (F 10) 2.2. Schizophrenia and associated conditions (F20) 2.3. Bipolar disorder (F30,31) |
| Date of first enrolment | 01/11/2008 |
| Date of final enrolment | 01/05/2010 |
Locations
Countries of recruitment
- Germany
Study participating centre
10115
Germany
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | results | 01/09/2013 | Yes | No | |
| Participant information sheet | Participant information sheet | 11/11/2025 | 11/11/2025 | No | Yes |